AstraZeneca PLC (AZN.L)
22 May 2013
|Market Cap (Mil.):||£42,758.30|
|Shares Outstanding (Mil.):||1,251.39|
LONDON - AstraZeneca is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry sources said.
* New research centre and corporate HQ to cost some $500 mln
LONDON - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers on a promise to accelerate its oncology programs.
* Final-stage studies on olaparib, selumetinib start in H2
* Early-stage research but scientists see momentum building
LONDON, April 25 - Britain's top share index traded flat on Thursday, steadying after recent robust gains, with falls in stocks such as AstraZeneca and Unilever on weak corporate earnings pegging the market back.
LONDON - AstraZeneca's sales fell by a bigger-than-expected 13 percent in the first quarter as patent expiries took a heavy toll, underscoring the turnaround challenge facing Britain's second-largest drugmaker.
* Q1 sales fall 13 pct to $6.39 bln vs consensus $6.51 bln
LONDON - AstraZeneca said on Thursday it had received a subpoena from the U.S. Attorney's Office in Boston, Massachusetts, related to manufacturing standards at its Macclesfield facility in the north of England.
LONDON, April 25 - AstraZeneca said on Thursday it had received a subpoena from the U.S. Attorney's Office in Boston, Massachusetts, related to manufacturing standards at its Macclesfield facility in the north of England.
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Provider: Market Edge
Provider: S&P Capital IQ – STARS Reports
AstraZeneca PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Pechala's Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.